Nam Su Lee

591 total citations
10 papers, 167 citations indexed

About

Nam Su Lee is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Nam Su Lee has authored 10 papers receiving a total of 167 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 3 papers in Surgery. Recurrent topics in Nam Su Lee's work include Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Neuroblastoma Research and Treatments (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Nam Su Lee is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Neuroblastoma Research and Treatments (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Nam Su Lee collaborates with scholars based in South Korea, United States and Australia. Nam Su Lee's co-authors include Jong-Ho Won, Hee Sook Park, Sang‐Cheol Lee, Kyoung Ha Kim, Hyun Jung Kim, Dae Sik Hong, Kyu Taek Lee, Chan Kyu Kim, Han Jo Kim and Jina Yun and has published in prestigious journals such as Lung Cancer, Cancer Chemotherapy and Pharmacology and Journal of Korean Medical Science.

In The Last Decade

Nam Su Lee

10 papers receiving 163 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nam Su Lee South Korea 9 70 65 53 36 26 10 167
Jie Bai China 11 81 1.2× 40 0.6× 72 1.4× 75 2.1× 8 0.3× 26 294
Fuminori Ito Japan 12 41 0.6× 35 0.5× 37 0.7× 61 1.7× 13 0.5× 24 371
Ece Dilege Türkiye 10 103 1.5× 52 0.8× 194 3.7× 44 1.2× 20 0.8× 20 314
Ștefan Morărașu Romania 9 45 0.6× 52 0.8× 68 1.3× 11 0.3× 27 1.0× 37 155
Célia Turco France 9 77 1.1× 119 1.8× 105 2.0× 21 0.6× 10 0.4× 26 225
Stefania Martini Italy 11 113 1.6× 75 1.2× 90 1.7× 23 0.6× 20 0.8× 21 284
Sonja Wagner Austria 8 27 0.4× 20 0.3× 38 0.7× 55 1.5× 41 1.6× 14 284
Yun Hwa Jung South Korea 9 39 0.6× 66 1.0× 35 0.7× 41 1.1× 7 0.3× 29 221
Matthias Lindner Germany 9 28 0.4× 64 1.0× 30 0.6× 38 1.1× 29 1.1× 17 303
N. Firusian Germany 8 117 1.7× 70 1.1× 58 1.1× 14 0.4× 8 0.3× 27 263

Countries citing papers authored by Nam Su Lee

Since Specialization
Citations

This map shows the geographic impact of Nam Su Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nam Su Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nam Su Lee more than expected).

Fields of papers citing papers by Nam Su Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nam Su Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nam Su Lee. The network helps show where Nam Su Lee may publish in the future.

Co-authorship network of co-authors of Nam Su Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Nam Su Lee. A scholar is included among the top collaborators of Nam Su Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nam Su Lee. Nam Su Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kim, Hyun Jung, Jina Yun, Han Jo Kim, et al.. (2012). Phase II study of palliative S-1 in combination with cisplatin as second-line chemotherapy for gemcitabine-refractory pancreatic cancer patients. Oncology Letters. 3(6). 1314–1318. 9 indexed citations
2.
Kim, Hyun Jung, Han Jo Kim, Jina Yun, et al.. (2012). Pathophysiological Role of Hormones and Cytokines in Cancer Cachexia. Journal of Korean Medical Science. 27(2). 128–128. 42 indexed citations
3.
Kim, Han Jo, Young‐Woo Jeon, Jina Yun, et al.. (2011). Efficacy and Safety of Oxaliplatin, 5-Fluorouracil, and Folinic Acid Combination Chemotherapy as First-Line Treatment in Metastatic or Recurrent Gastric Cancer. Cancer Research and Treatment. 43(3). 154–159. 10 indexed citations
4.
Kim, Han Jo, Kyoung Ha Kim, Jina Yun, et al.. (2011). Phase II Clinical Trial of Genexol(R) (Paclitaxel) and Carboplatin for Patients with Advanced Non-small Cell Lung Cancer. Cancer Research and Treatment. 43(1). 19–23. 12 indexed citations
5.
Yun, Jina, Han Jo Kim, Kyoung Ha Kim, et al.. (2011). Clinical Outcome of Gastric Cancer Patients with Bone Marrow Metastases. Cancer Research and Treatment. 43(4). 244–249. 34 indexed citations
6.
Lee, Hae‐Seung, Hyun Jung Kim, Chan Kyu Kim, et al.. (2010). A Case of Type B Lactic Acidosis in Acute Leukemia. Yonsei Medical Journal. 51(3). 460–460. 8 indexed citations
7.
Ahn, Myung‐Ju, Winnie Yeo, Jin Seok Ahn, et al.. (2009). Adenocarcinoma has an excellent outcome with pemetrexed treatment in Korean patients: A prospective, multicenter trial. Lung Cancer. 66(3). 338–343. 9 indexed citations
8.
Lee, Sang‐Cheol, Kyoung Ha Kim, Sung‐Han Kim, et al.. (2009). Mixed Testicular Germ Cell Tumor Presenting as Metastatic Pure Choriocarcinoma Involving Multiple Lung Metastases That Was Effectively Treated with High-dose Chemotherapy. Cancer Research and Treatment. 41(4). 229–229. 10 indexed citations
9.
Jee, Yong‐Seok, Tae‐You Kim, Myung Ah Lee, et al.. (2007). Phase II trial of gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas. Cancer Chemotherapy and Pharmacology. 61(1). 47–52. 30 indexed citations
10.
Lee, Nam Su, et al.. (1996). Case Report : Idiopathic Granulomatous Hepatitis Manifested with Fever of Unknown Origin. The Korean Journal of Internal Medicine. 11(2). 161–164. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026